23 related articles for article (PubMed ID: 2900051)
1. Somatostatin, Olfaction, and Neurodegeneration.
Saiz-Sanchez D; Ubeda-Bañon I; Flores-Cuadrado A; Gonzalez-Rodriguez M; Villar-Conde S; Astillero-Lopez V; Martinez-Marcos A
Front Neurosci; 2020; 14():96. PubMed ID: 32140092
[TBL] [Abstract][Full Text] [Related]
2. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
[TBL] [Abstract][Full Text] [Related]
3. Molecular pharmacology of somatostatin receptors.
Hoyer D; Lübbert H; Bruns C
Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):441-53. PubMed ID: 7870182
[TBL] [Abstract][Full Text] [Related]
4. Distribution of neuropeptide Y in the prosencephalon of man and cotton-head tamarin (Saguinus oedipus): colocalization with somatostatin in neurons of striatum and amygdala.
Schwartzberg M; Unger J; Weindl A; Lange W
Anat Embryol (Berl); 1990; 181(2):157-66. PubMed ID: 1970228
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptides in Alzheimer's disease: a review and morphological results.
Bouras C; de St Hilaire-Kafi S; Constantinidis J
Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):271-86. PubMed ID: 2432629
[TBL] [Abstract][Full Text] [Related]
6. NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.
Unger JW; Lange W
Acta Neuropathol; 1992; 83(6):636-46. PubMed ID: 1378987
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.
Benzing WC; Mufson EJ; Armstrong DM
Brain Res; 1993 Oct; 625(1):125-38. PubMed ID: 8242391
[TBL] [Abstract][Full Text] [Related]
8. The amygdala in Alzheimer's disease: neuropathology and Alz 50 immunoreactivity.
Unger JW; Lapham LW; McNeill TH; Eskin TA; Hamill RW
Neurobiol Aging; 1991; 12(5):389-99. PubMed ID: 1837592
[TBL] [Abstract][Full Text] [Related]
9. Selective lesion of the cholinergic basal forebrain causes a loss of cortical neuropeptide Y and somatostatin neurons.
Zhang ZJ; Lappi DA; Wrenn CC; Milner TA; Wiley RG
Brain Res; 1998 Aug; 800(2):198-206. PubMed ID: 9685641
[TBL] [Abstract][Full Text] [Related]
10. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques.
Unger JW; McNeill TH; Lapham LL; Hamill RW
Brain Res; 1988 Jun; 452(1-2):293-302. PubMed ID: 2900051
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides in Alzheimer's disease.
Beal MF; Kowall NW; Mazurek MF
J Neural Transm Suppl; 1987; 24():163-74. PubMed ID: 2445913
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
